ATLANTA and CHICAGO, June 1 /PRNewswire/ -- For the fourth consecutive year, Elekta
Elekta is among 11 providers chosen to present at the EHR Lab, a forum for ASCO members to discover the latest EHR technology. This year, providers will demonstrate how their solutions can:
During the Lab, Elekta will provide hands-on demonstrations of MOSAIQ®, its EHR designed for use in medical oncology and radiation oncology environments. MOSAIQ has helped large and small practices worldwide reduce costs, enhance efficiency and strengthen business performance.
"MOSAIQ is a comprehensive, integrated EHR that we have implemented in hundreds of hospitals and clinics," says Donna Getreuer, Director of Medical Oncology Business Marketing for Elekta. "We intend to show how MOSAIQ is the optimal solution to create a seamless oncology information infrastructure, and also how Elekta, as a stable provider with a long history in information management -- can guide users on ways they can qualify for government monies when they implement an EHR."
As part of the economic stimulus bill, the federal government allocated $19.2 billion dollars in incentives to encourage the adoption of EHRs among physicians and hospitals. This portion of this bill is entitled the Health Information Technology for Economic and Clinical Health Act, or HITECH Act, and strongly encourages the health care industry to go paperless by 2015.
To download a complimentary copy of Elekta's HITECH Act Action Plan, visit www.elekta.com/hitech. For the latest MOSAIQ news, stop by booth #15088 in the McCormick Place exhibit hall, or visit www.elekta.com/mosaiq.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.
Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible today.
Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.
Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.
Subscribe to our Free Newsletters!
Uterine/Endometrial cancer is the sixth most common cancer in women worldwide. Uterine cancer ...
Bladder neck incision is a surgical procedure where cuts are made in the neck of the urinary ...
Tourette syndrome (TS) is a neurological disorder wherein the affected person makes repetitive and ...View All